Karine Tawagi, Assistant Professor of Clinical Medicine and Fellowship Program Director at the University of Illinois Chicago, shared a post on X:
”Full house for KN564 exome-based ctDNA analysis
- ctDNA+ at baseline was ass w/ worse DFS to adj pembro & pbo
- RCC remains low shedding – baseline ctDNA positivity very low (5.4-8.2%)
- Specificity for recurrence high (96-99%), sensitivity low (10-15%).”
Other Articles Featuring Karine Tawagi On OncoDaily.
